Dominari (DOMH) has had the highest return since January 1, 2025 by a US stock with a market cap of $100+, returning 528.6%.
| ASSET | % RETURN |
|---|---|
Dominari (DOMH) | 528.57% |
Wang & Lee Group, Inc Ordinary Shares (WLGS) | 394.25% |
Transcode Therapeutics (RNAZ) | 251.19% |
Invivyd (IVVD) | 234.04% |
Oncology Institute (TOI) | 226.8% |
Quantum BioPharma (QNTM) | 222.37% |
Rapid Micro Biosystems (RPID) | 209.89% |
Digital Turbine (APPS) | 209.2% |
Nuvve (NVVEW) | 207.09% |
Fubotv (FUBO) | 196.15% |
Society Pass (SOPA) | 188.57% |
Cyclo Therapeutics (CYTHW) | 185.71% |
Noodles (NDLS) | 163.29% |
Compass Therapeutics (CMPX) | 160% |
Reborn Coffee (REBN) | 154.39% |
Oklo (OKLO) | 153.09% |
N2OFF (NITO) | 150.11% |
INNOVATE (VATE) | 148.34% |
Lottery, Inc Common Stock (LTRY) | 147.6% |
Biomerica (BMRA) | 142.58% |
Yoshiharu Global (YOSH) | 139.39% |
Lightbridge (LTBR) | 136.23% |
Monopar Therapeutics (MNPR) | 135.86% |
Chromocell Therapeutics (CHRO) | 134.33% |
Neuronetics (STIM) | 133.94% |
